Aberdeen Group Portfolio holdings
AUM
$64.6B
1-Year Est. Return
29.34%
This Fund
S&P 500
1 Year Est. Return
+29.34%
AUM
$64.6B
AUM Growth
+$1.37B
(+2.2%)
Holding
995
Top Buys
| 1 | +$36.3M | |
| 2 | +$36.1M | |
| 3 | +$35.6M | |
| 4 |
Danaher
DHR
|
+$30.5M |
| 5 |
uniQure
QURE
|
+$28.5M |
Top Sells
| 1 | +$93.5M | |
| 2 | +$86M | |
| 3 | +$62.9M | |
| 4 |
Apple
AAPL
|
+$55.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$48.9M |
Sector Composition
| 1 | Technology | 32.59% |
| 2 | Healthcare | 13.39% |
| 3 | Consumer Discretionary | 11.41% |
| 4 | Communication Services | 11.25% |
| 5 | Financials | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Veracyte
VCYT
$3.06B
| – | – |
-162,102
|
|
||
|
WNS
977
DELISTED
WNS Holdings
WNS
| – | – |
-5,884
|
|
||
|
RAL
978
Ralliant Corp
RAL
$5.3B
| – | – |
-38,792
|
|
||
979
Exact Sciences
EXAS
$19.7B
| – | – |
-304,609
|
|
||
|
HPP
980
Hudson Pacific Properties
HPP
$417M
| – | – |
-300,638
|
|
||
|
IAS
981
DELISTED
Integral Ad Science
IAS
| – | – |
-335,915
|
|
||
|
NBP
982
NovaBridge Biosciences American Depositary Shares
NBP
$378M
| – | – |
-43,738
|
|
||
983
Indivior Pharmaceuticals
INDV
$4.21B
| – | – |
-160,717
|
|
||
984
Janux Therapeutics
JANX
$830M
| – | – |
-345,476
|
|
||
|
K
985
DELISTED
Kellanova
K
| – | – |
-288,477
|
|
||
986
CarMax
KMX
$6.08B
| – | – |
-8,733
|
|
||
987
Korro Bio
KRRO
$114M
| – | – |
-57,983
|
|
||
988
VanEck Morningstar Wide Moat ETF
MOAT
$13.1B
| – | – |
-12,008
|
|
||
989
Nice
NICE
$7.16B
| – | – |
-1,975
|
|
||
990
Nutanix
NTNX
$10.8B
| – | – |
-5,163
|
|
||
991
Owens Corning
OC
$10.1B
| – | – |
-32,639
|
|
||
992
On Holding
ONON
$15.7B
| – | – |
-768,053
|
|
||
993
Xencor
XNCR
$968M
| – | – |
-558,810
|
|
||
|
ZK
994
DELISTED
Zeekr
ZK
| – | – |
-8,863
|
|
||
|
PVLA
995
Palvella Therapeutics
PVLA
$1.76B
| – | – |
-51,243
|
|